Molecular therapy for the treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Conventional cytotoxic chemotherapy has failed to show a substantial benefit for patients with HCC. Recently, a number of new drugs targeting molecular mechanisms involved in liver cell transformation have entered into clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Greten, T F, Korangy, F, Manns, M P, Malek, N P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634687/
https://www.ncbi.nlm.nih.gov/pubmed/19018262
http://dx.doi.org/10.1038/sj.bjc.6604784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634687/
https://www.ncbi.nlm.nih.gov/pubmed/19018262
http://dx.doi.org/10.1038/sj.bjc.6604784

Ejemplares similares